Effects of Home-based Inspiratory Muscle Training in Patients With IPF
1 other identifier
interventional
28
1 country
1
Brief Summary
The aim of this study is to investigate the effects of the home-based inspiratory muscle training program on lung functions, dyspnea, inspiratory muscle strength, functional capacity and quality of life in patients with idiopathic pulmonary fibrosis. Patients are evaluated before the inspiratory muscle training and after 8 weeks of training.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 21, 2022
CompletedFirst Submitted
Initial submission to the registry
April 25, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 25, 2022
CompletedFirst Posted
Study publicly available on registry
April 29, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2022
CompletedJanuary 10, 2024
January 1, 2024
2 months
April 25, 2022
January 8, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in inspiratory muscle strength
MIP
8 weeks
Secondary Outcomes (5)
Change in percentages of forced expiratory volume in one second
8 weeks
Change in percentages of forced vital capacity
8 weeks
Change in diffusing capacity of the lung for carbon monoxide
8 weeks
Change in Dyspnea
8 weeks
Change in Functional capacity
8 weeks
Study Arms (2)
Study Group
EXPERIMENTALPatients who perform inspiratory muscle training (IMT) with %50 loading
Sham Group
SHAM COMPARATORPatients who perform Sham IMT
Interventions
The IMT protocol will consist of home-based high-intensity daily training - two cycles of 30 breaths with a 1-min rest between sets, twice a day for 8 weeks using an IMT Threshold device (Threshold IMT Philips® Respironics, Inc). The intensity of the training will be set to 50% of each patient's maximal inspiratory pressure measured every week and was adjusted weekly based on the modified Borg scale from 4 to 6 regarding respiratory effort performed during the session.
The IMT protocol will consist of home-based daily training - two cycles of 30 breaths with a 1-min rest between sets, twice a day for 8 weeks using an IMT Threshold device (Threshold IMT Philips® Respironics, Inc). The intensity of the training will be set to the lowest intensity of the IMT Threshold device.
Eligibility Criteria
You may qualify if:
- Diagnosing Idiopathic Pulmonary Fibrosis by a pulmonologist;
- Aged between 40 and 75 years;
- Volunteering to research;
- Stable clinical condition (same medication routine and/or no acute exacerbation in the last for the last 4 weeks).
You may not qualify if:
- Inability of the participant to understand or perform the procedures proposed during the evaluations or training program.
- Participating in any pulmonary rehabilitation programs;
- A previous pneumonectomy or lobectomy operation;
- Pneumonia in the last 4 weeks;
- Any pulmonary infection during the study;
- Requirement for supplemental oxygen therapy while resting.
- Having Covid-19 disease (during the study or in the past)
- Orthopaedic or neurological conditions affecting the ability to independent walking
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dokuz Eylul University
Izmir, Balcova, 35330, Turkey (Türkiye)
Related Publications (5)
Selman M, Thannickal VJ, Pardo A, Zisman DA, Martinez FJ, Lynch JP 3rd. Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approaches. Drugs. 2004;64(4):405-30. doi: 10.2165/00003495-200464040-00005.
PMID: 14969575BACKGROUNDJastrzebski D, Kozielski J, Zebrowska A. [Pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis with inspiratory muscle training]. Pneumonol Alergol Pol. 2008;76(3):131-41. Polish.
PMID: 18843927BACKGROUNDKagaya H, Takahashi H, Sugawara K, Kasai C, Kiyokawa N, Shioya T. Effective home-based pulmonary rehabilitation in patients with restrictive lung diseases. Tohoku J Exp Med. 2009 Jul;218(3):215-9. doi: 10.1620/tjem.218.215.
PMID: 19561392BACKGROUNDTzanakis N, Samiou M, Lambiri I, Antoniou K, Siafakas N, Bouros D. Evaluation of health-related quality-of-life and dyspnea scales in patients with idiopathic pulmonary fibrosis. Correlation with pulmonary function tests. Eur J Intern Med. 2005 Apr;16(2):105-112. doi: 10.1016/j.ejim.2004.09.013.
PMID: 15833676BACKGROUNDPeng S, Li Z, Kang J, Hou X. Cross-sectional and longitudinal construct validity of the Saint George's Respiratory Questionnaire in patients with IPF. Respirology. 2008 Nov;13(6):871-9. doi: 10.1111/j.1440-1843.2008.01359.x.
PMID: 18811886BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rıdvan Aktan, PhD
Izmir University of Economics
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, PhD
Study Record Dates
First Submitted
April 25, 2022
First Posted
April 29, 2022
Study Start
February 21, 2022
Primary Completion
April 25, 2022
Study Completion
May 30, 2022
Last Updated
January 10, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will not share